VC  Watson Fund

http://www.watsonfund.com/





     Office Locations:

1616 Eastlake Ave E., Suite 200
Seattle, WA 98102
Phone: 206-957-7300

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Watson Fund, L.P. is a healthcare venture capital fund that specializes in early-stage investments in a broad range of life science opportunities. Watson Fund largely invests in opportunities developed and managed by Accelerator Corporation (see profile), with reserves set aside for follow-on investments in companies that meet pre-defined milestones.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Thong Q. Le CEO

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/13/2018


      Magnolia Neurosciences


      NY


      $31,000,000


      Series A


      04/27/2018


      Proniras


      WA


      undisclosed


      


     

    Portfolio companies include:

     

    Recent News: